Investor's Business Daily on MSN2h
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 BillionGSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...
We recently compiled a list of the 10 Best Foreign Stocks With Dividends For Passive Income. In this article, we are going to ...
TD Cowen analyst Steve Scala maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The company’s ...
The Delhi High Court on February 3 passed an interim injunction restraining a pharmaceutical company from using the trademark ...
Chicago Partners Investment Group LLC bought a new stake in shares of Novartis AG (NYSE:NVS – Free Report) during the 4th ...
This launch builds on the successful collaboration between Dawn Health and Novartis, following the development of Ekiva MS and Ekiva PNH, and underscores the potential of digital health to transform ...
Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback